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ABSTRACT  28 
Background 29 
The implementation of lockdowns in the UK during the COVID-19 pandemic resulted in a 30 
system switch to remote primary care consulting at the same time as the incidence of 31 
domestic violence and abuse (DVA) increased. Lockdown-specific barriers to disclosure of 32 
DVA reduced the opportunity for DVA detection and referral.  33 
The PRECODE (PRimary care rEsponse to domestic violence and abuse in the COvid-19 34 
panDEmic) study will comprise quantitative analysis of the impact of the pandemic on 35 
referrals from IRIS (Identification and Referral to Improve Safety) trained general practices to 36 
DVA agencies in the UK and qualitative analysis of the experiences of clinicians responding 37 
to patients affected by DVA and adaptations they have made transitioning to remote DVA 38 
training and patient support.  39 
Methods 40 
Using a rapid mixed method design, PRECODE will explore and explain the dynamics of 41 
DVA referrals and support before and during the pandemic on a national scale using 42 
qualitative data and over four years of referrals time series data.    43 
We will undertake interrupted-time series and non-linear regression analysis, including 44 
sensitivity analyses, on time series of referrals to DVA services from routinely collected data 45 
to evaluate the impact of the pandemic and associated lockdowns on referrals to the IRIS 46 
Programme, and analyse key determinants associated with changes in referrals.  47 
We will also conduct interview- and observation-based qualitative study to understand the 48 
variation, relevance and feasibility of primary care responses to DVA before and during the 49 






The triangulation of quantitative and qualitative findings using rapid analysis and synthesis 52 
will enable the articulation of multiscale trends in primary care responses to DVA and 53 
complex mechanisms by which these responses have changed during the pandemic. 54 
Discussion 55 
Our findings will inform the implementation of remote primary care and DVA service 56 
responses as services re-configure. Understanding the adaptation of clinical and service 57 
responses to DVA during the pandemic is crucial for the development of evidence-based, 58 
effective remote support and referral beyond the pandemic.  59 
Trial registration  60 
PRECODE is an observational epidemiologic study, not an intervention evaluation or trial. We 61 
will not be reporting results of an intervention on human participants.  62 
 63 
KEYWORDS  64 
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 68 
[MAIN TEXT] 69 
BACKGROUND 70 
Domestic violence and abuse during the COVID-19 pandemic  71 
The global incidence of domestic violence and abuse (DVA) has increased notably during 72 
the COVID-19 pandemic in association with strict social distancing measures (lockdowns), 73 
widespread anxiety, increased economic precarity, and reduced access to support services 74 





shutting down or limiting usual routes to support and safety could have a detrimental impact 76 
on the health and wellbeing of people affected by DVA and their families (9, 10).  77 
 78 
Although DVA prevalence figures largely differ internationally due to variations in 79 
measurement techniques (11), even before the pandemic the incidence was high globally 80 
(11-13). In the UK, according to the Office for National Statistics (ONS), 7.3% of women and 81 
3.6% of men nationally have experienced DVA in a year (14) and life-time population 82 
prevalence is consistently higher for women seeking health care (15), including primary care 83 
(16). Women experience more repeated and severe abuse, sexual violence, and coercive 84 
control (17).  85 
DVA is a violation of human rights that damages health and wellbeing. It requires a multi-86 
sectoral response, including a vital role of health care services in responding to affected 87 
patients (18-21). A major part of this health care response is identification of people who are 88 
affected by abuse and enabling access to appropriate support to enhance their safety and 89 
improve their health outcomes. In the United Kingdom (UK), that specialist support largely 90 
comes from third sector DVA agencies.  91 
 92 
Primary health care response to DVA  93 
 94 
There are international (22) and national UK (23) guidelines for the healthcare of women 95 
affected by DVA, and a growing recognition of its impact on their health (24, 25). Over the 96 
past decade, in line with guidelines, UK general practice has started to engage with DVA, 97 
with training of general practice teams in the identification, support and referral of female 98 
patients affected by abuse from a partner/spouse or other adult in the household.  99 
 100 
General practice can provide a safe and confidential place for disclosure and enquiry about 101 





has a strong evidence base, particularly the landmark IRIS (Identification and Referral to 103 
Improve Safety) trial (26) and subsequent interrupted time series (27), showing effective 104 
implementation and cost-effectiveness (28). The IRIS programme, which is facilitated and 105 
monitored by IRISi, a social enterprise (29), has been commissioned in 48 areas and has 106 
trained over 1,000 practices (>12%) in England, Wales, the Channel Islands and Northern 107 
Ireland with over 20,500 female patients referred from these practices in the past 10 years. 108 
 109 
The implementation of lockdowns in the UK resulted in the majority of medical consultations 110 
in primary care shifting to audio or video encounters with patients (30, 31). Lockdown-111 
specific barriers to disclosure of abuse (32) and barriers to general practice consultations 112 
linked to the system switch to remote consulting (33) have occurred at the same time as the 113 
incidence of abuse has increased (34). The overall drop in consultations (30) and diagnoses 114 
(35) during the pandemic has, however, reduced the opportunity for detection. DVA also 115 
remained easily hidden by the many varied presentations around common mental health 116 
problems linked to the pandemic (36, 37).  117 
 118 
The necessary transition to remote clinical consultations has uncovered safety and 119 
confidentiality concerns, practical challenges and knowledge gaps about how general practice 120 
clinicians can ask about abuse, respond appropriately and provide ongoing support (38). The 121 
requirement for additional skills and competencies for the management of telemedicine has 122 
also emerged. IRISi has developed and disseminated guidance (39) for general practices 123 
nationally on conducting safe remote consultations both directly and via the Royal College of 124 
General Practitioners (RCGP), National Health Service England (NHSE), and social media. 125 
The guidance raised awareness about the heightened risks and provided advice on 126 
overcoming barriers to enquiry, identification and referral to specialist services. Local IRIS 127 
providers are offering COVID-19-adapted online training to support implementation of the 128 






About PRECODE  131 
 132 
Aims and objectives 133 
In this paper we summarise the protocol for PRECODE (Primary Care Response to 134 
Domestic Violence and Abuse in the Covid-19 Pandemic: interrupted time series and 135 
qualitative study) which aims to understand the impact of the UK national COVID-19 136 
lockdowns on general practice responses to DVA. Using a rapid mixed method design, the 137 
study will explore the impact of the pandemic on the number of patient referrals from IRIS 138 
trained general practices to DVA agencies in the UK. It also aims to understand the 139 
experiences of primary care clinicians responding to patients affected by DVA during the 140 
pandemic and adaptations they have made transitioning to online DVA training and to 141 
remote DVA identification, support, and patient referral.  142 
 143 
Research questions 144 
To achieve these aims, the study will answer the following research questions:  145 
 146 
(1) What is the impact of the national COVID-19 lockdowns in the UK on the referral 147 
rates of patients affected by DVA in practices that have had IRIS DVA training and a 148 
specialist referral pathway?  149 
(2) How, if at all, have these practices adapted to online DVA training and to remote 150 
DVA identification, support, and patient referral? 151 
 152 
The integration of quantitative and qualitative approaches (workstreams) will enable the 153 
articulation of multiscale trends in primary care responses to DVA and complex mechanisms 154 
by which these responses to patients have changed during the pandemic.  155 





An established patient and public involvement and engagement (PPI&E) group of women 157 
survivors of DVA (supporting the REPROVIDE research programme (40) and meeting 158 
quarterly) has advised on the development of the proposal and will be consulted regularly 159 
throughout the duration of the study. We have also formed a dedicated PRECODE PPI&E 160 
group of survivors consisting of women who have experienced DVA and who have been 161 
supported by a DVA specialist service and local IRIS programmes. The PRECODE PPI&E 162 
group will meet quarterly and will work in close collaboration with the research team advising 163 
on study design, conduct, analysis, interpretation of findings and dissemination. In addition, 164 
we will also consult an established male DVA survivor group that advises on the 165 
REPROVIDE programme. All our PPI&E group members will have careful induction to 166 
ensure appropriate conduct, the safety and wellbeing of the group, and to enhance their 167 
engagement. The PPI&E meetings take place in a supportive and safe environment and are 168 
followed by de-briefing sessions. Members will be supported by their DVA organisations and 169 
will be also encouraged to seek additional support from our partner DVA agencies and from 170 
Bristol Medical School's Centre for Academic Primary Care PPI&E facilitator (41).  171 
 172 
Ethics and funding  173 
The study received HRA (Health Research Authority) and Health and Care Research Wales 174 
(HCRW) Approval (20/HRA/5873) and University of Bristol Faculty of Health Science 175 
Research Ethics Approval (113044).  176 
In addition, the University of Oxford, Medical Sciences Inter-Divisional Research Ethics 177 
Committee (IDREC) granted amendment approval to our aligned study exploring the 178 
experiences of general practitioners with remote consultations in non-IRIS practices in the 179 
UK ‘R69839/RE003 - Understanding GP (general practitioner) perspectives on the safe and 180 
effective delivery of safeguarding’ to conduct a secondary analysis and integrate findings 181 





PRECODE is a 12-month third sector-cross universities collaborative project and is funded 183 
by the UKRI (UK Research and Innovation) Rapid Response Call and the (MRC) Medical 184 
Research Council MR/V041533/1.  185 
METHODS AND ANALYSIS 186 
Quantitative Workstream: impact of COVID-19 social distancing measures 187 
(lockdowns) on referral rates of patients affected by DVA  188 
Aims and objectives 189 
We will analyse the numbers of referrals from general practices to the IRIS service to: 190 
(i) quantify the impact of the three national COVID-19 lockdowns and social 191 
distancing restrictions on referrals to IRIS services during 2020 and 2021 192 
(ii) quantify the difference in the number of referrals during school holidays 193 
(periods when the number of IRIS referrals consistently dip) over different 194 
years between 2017-2020 and contrast these to referrals during the national 195 
lockdowns in 2020 and 2021 196 
(iii) determine the key factors significantly associated with increased referrals 197 
during school holidays and during the national lockdowns in the period 198 
between 2017-2021.  199 
 200 
Measurements and data collection 201 
We will quantify the number of general practice referrals of female patients to a local IRIS 202 
programme for specialist DVA support from March 2017 to September 2021. We will use 203 
routinely collected practice-level referral data from 33 sites where IRIS was commissioned 204 
for at least 12 months before the UK announced its first national lockdown on the 23rd of 205 
March 2020. In line with our previously published work (42, 43) data will include anonymised 206 





agencies from general practices across 33 sites between 24/03/2017- 22/9/2021 for female 208 
patients aged 16 and above, registered at a general practice.  209 
It is estimated that 14,000 to 15,000 individual level referrals will constitute the final sample 210 
size, given that between 1st April 2017 and 1st April 2020 IRIS has received 4,934 referrals to 211 
the programme.  212 
 213 
Statistical analysis 214 
Two separate but related analyses will be completed as part of this workstream.  215 
In the first analysis, we will evaluate the impact of the pandemic and associated lockdowns 216 
on referrals to the IRIS Programme (referrals to IRIS advocate educators in specialist DVA 217 
services) and compare these to the referrals during school holidays between 2017-2020. We 218 
will undertake interrupted-time series (ITS) (44) and non-linear regression analysis, including 219 
sensitivity analyses, on time series of referrals to DVA services from routinely collected 220 
practice level data across 33 local authority or Clinical Commissioning Group (CCG) areas. 221 
We will fit different regression models to the data. For each regression model, we will 222 
calculate the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC) 223 
to compare models and choose the best-fit model based on the smallest values of these 224 
quantities.  225 
For the best-fit model, we will report incidence rate ratios (IRR) and 95% confidence 226 
intervals as indicators of change in referrals before and during the first, second and third 227 
national lockdowns in 2020 and 2021 and during the school holidays in 2017/2018 and 228 
2018/2019. This will allow us to quantify and contrast the impact and significance of the 229 
lockdowns and school holidays on the referrals. The periods of analysis will be: 01/4/2017-230 
31/12/2019 (initial analysis of the impact of school holidays); 24/3/2019-23/9/2020 (initial 231 
analysis of the impact of the first national lockdown), 24/3/2019-22/9/2021 (final analysis of 232 





track the effect of reopening society following the third national lockdown in 2021 after the 234 
roll-out of the COVID-19 vaccination campaign.   235 
The second analysis will explore key determinants associated with increased referral to the 236 
IRIS programme. We will explore whether these were different in the period before the 237 
pandemic (April 2017-December 2019) and during the pandemic (January 2020-December 238 
2020). We will also explore the impact of training and guidance on referrals, given that within 239 
two weeks of the implementation of national social distancing/isolation policy and the shift to 240 
remote consultation, all IRIS practices were issued guidance and were offered COVID-19-241 
specific online training to support implementation of the guidance on safe remote 242 
consultations. We will have area-level data on number of trainings that took place online. In 243 
a difference-in-difference analysis of referrals data, we will estimate the effect of that 244 
training. If possible, we will run an additional sensitivity analysis, using the local prevalence 245 
of DVA as reported to the police, based on the local Joint Strategic Needs Assessment 246 
(JSNA) or local office for policing and crime to adjust the ITS model in relation to incidence, 247 
once a chance in incidence may cofound that analysis of referral rates. Regression results 248 
for this second analysis will be presented as marginal effects or incidence rate ratios. 249 
All quantitative analysis will be carried out using Stata MP 15.  250 
Qualitative workstream: understanding adaptations to remote domestic abuse 251 
consultations, referral and training  252 
Aims and objectives 253 
We will conduct an interview- and observation-based qualitative study to understand: 254 
(i) the feasibility and utility of online training, the extent to which clinicians were able 255 
to implement national guidance and online training on safe remote consultations, 256 
support, and patient referral 257 
(ii) primary care clinicians’ views and experiences responding to affected patients 258 





(iii) organisational and individual practice adaptations and strategies addressing 260 
concerns and mitigating challenges around consultation safety, confidentiality 261 
and efficacy as a result of transitioning to telemedicine.   262 
 263 
Sampling and recruitment  264 
We will conduct interviews with professionals who are key in either providing support to 265 
patients affected by DVA or in reconfiguring how practices implement remote consultations. 266 
Participants will include (1) practice managers and practice administrative staff who 267 
managed or facilitated the move to remote consulting; (2) primary care clinicians who 268 
conducted routine and urgent primary care clinical consultations during the pandemic; (3) 269 
IRISi regional managers who oversaw and supported the implementation of the IRIS 270 
programme; and (4) IRIS advocate educators who (i) supported and provided on-going 271 
training for general practice teams to help them understand and respond to DVA during the 272 
pandemic (ii) received and responded to domestic abuse referrals for patients affected and 273 
provided specialist support to them.  274 
 275 
Participants will be identified using purposive maximum variation sampling of professionals 276 
from up to 15 IRIS trained general practices, interviewing approximately 30 primary care 277 
practice clinicians and 15 non-clinical professionals (regional managers, advocate educators 278 
and practice managers). We will apply a multi-stage sampling framework. We will select up 279 
to eight sites where the IRIS programme is commissioned, usually a CCG or local authority 280 
area, during the first stage of sampling (area selection). The area selection will be informed 281 
by the initial analysis of referral rates/patterns from the quantitative workstream examining 282 
referrals across different regions and variations in DVA referrals before and during the first 283 
UK pandemic wave. Area selection will be also informed by patient population size and 284 
demographic and socio-economic composition. Sampling decisions will be guided by 285 
insights from IRISi regional managers either through formal interviews (see above) or via co-286 





The second stage of sampling will take place within selected geographic areas and will be 288 
based on general practice referral rates. In partnership with local advocate educators, who 289 
hold links with general practices and have local knowledge of the implementation of the IRIS 290 
programme in general practices, we will identify two dissimilar general practices (for example 291 
historically high and low referrers; uncharacteristically higher or lower referrers during the 292 
pandemic). Finally, our sampling approach, using a ‘snowballing’ sampling technique for the 293 
identification of individuals, will also consider the inclusion of participants from diverse 294 
demographic groups, those with diverse professional backgrounds and experiences, and 295 
those with different levels of involvement in the IRIS programme.  296 
We will exclude professionals from the qualitative study who were not actively in post for at 297 
least three months from the beginning of the first national lockdown (23/03/2020) (i.e. did not 298 
conduct patient consultations (primary care clinicians) or did not deliver at least one online 299 
training session (advocate educators).   300 
 301 
Local advocate educators will be asked to share details of the study (study summary and 302 
invitation letter) with the practice manager and a known primary care clinician with 303 
experience in IRIS referral from each practice. The clinician will be asked to recommend 304 
another clinician colleague from their practice with less involvement with IRIS to join the 305 
study. Participants will be asked to directly contact the researchers who will explain the study 306 
and will share the information sheet. If they indicate to the researcher that they are willing to 307 
take part in an interview and meet the sampling and study inclusion criteria, a suitable 308 
interview time will be arranged with the individuals directly or via the practice manager. Up to 309 
eight local advocate educators and regional managers working with different sites and 310 
regions will also be invited to participate in an interview. We will seek consent from 311 
individuals to participate in the study and to being audio-recorded prior to the 312 






We will also observe ten remotely delivered IRIS training sessions. Our sampling units for 315 
the observation will be general practices, not individual clinicians. Therefore, clinicians for 316 
the training observation will be recruited as a clinical team via the practice manager. 317 
Observed practices will be sampled to represent a mixture of practices by geographical 318 
location, demographic and socio-economic composition of population, practice size and IRIS 319 
referral rates. Practice recruitment will be supported by IRISi regional managers and guided 320 
by local advocate educators. We will seek permission to observe training sessions from 321 
advocate educators, practice managers and clinicians.  322 
 323 
Data collection  324 
Semi-structured interviews will be conducted with general practice clinicians, advocate 325 
educators, regional managers, and practice managers remotely (via phone or video call). 326 
The interviews will be focusing on experiences of the management of DVA in primary care 327 
during the pandemic and views about the relevance, feasibility and utility of online DVA 328 
training. The semi-structured interviews will explore concerns with and experiences of asking 329 
(or not) about domestic abuse; relevance and availability of guidance; obstacles to and 330 
strategies for offering support and referral. Interviews with practice managers, regional 331 
managers and advocate educators will give insights into local adaptations, and about 332 
organisational and practical barriers and facilitators to delivering online training. Interviews 333 
will be audio recorded and transcribed verbatim.  334 
  335 
We will also remotely (via video call) observe approximately ten online training sessions. The 336 
observations will document the context and dynamics of training sessions, variations in 337 
training delivery, participants’ engagement with and reflections on the content and 338 
participants’ questions and concerns. Observations will be guided by an observation 339 
framework and will be summarised in detailed field notes. 340 
 341 





We will apply rapid qualitative analysis techniques adapted from McNall and Foster-343 
Fishman (45) and Vindrola-Padros et al. (46). After each interview/observation the 344 
researcher will prepare a Rapid Assessment Procedure (RAP) summary sheet (47) to 345 
provide familiarisation and research team access to the qualitative data. These short 346 
summaries will be shared among the research team in advance of full transcripts and 347 
fieldnotes becoming available, enabling discussion of developing themes and iterative 348 
adaptation to topic guides. The qualitative research team will meet regularly to carry out 349 
group analysis of full transcripts and observation fieldnotes and to develop an initial coding 350 
framework following the Framework Method (48) as appropriate for rapid group analysis. 351 
Once the framework is agreed it will be applied across all transcripts and fieldnotes and 352 
data will be charted in a shared excel spreadsheet. At this stage, researchers will explore 353 
different framework categories for thematic insights, and will conduct further sub-analyses 354 
as deemed relevant for answering the initial research questions, as well as responding to 355 
unanticipated topics within the data.  356 
Synthesis of quantitative and qualitative workstreams   357 
We will synthesise key initial findings from the qualitative and quantitative workstreams. The 358 
synthesis will lead to new insights beyond those identified in each workstreams. Exploratory 359 
and explanatory sequential mixed method data analysis (49, 50) will involve using the initial 360 
findings of the ITS to sample areas for interviews, based on variation in referral rates. 361 
Further ITS analysis will proceed in parallel with the qualitative interviews, leading to the 362 
synthesis stage in which we will triangulate the findings of the complete ITS with qualitative 363 
findings. We will explore temporal variation in the referral rates and variation between areas 364 
with interview data, generating hypotheses (51) to explain the variations. The initial findings 365 
of the ITS are likely to show a reduction in IRIS referrals from general practice, despite other 366 
external evidence (from national DVA helpline, domestic homicide data, police reports) that 367 
incidence rose during the first and subsequent lockdowns. The interviews with primary care 368 





appointments and consultations, barriers to disclosure and perceptions of what DVA 370 
agencies can offer patients who do disclose. We will use timelining (52) to map clinician 371 
experiences of asking about and referring (or not referring) patients affected by DVA. The 372 
timeline will correspond to the time window of the ITS analysis, but extended to the date of 373 
the interview, to capture changes in their consultation and referral behaviour and external 374 
circumstances. Interviews with advocate educators, regional managers and practice 375 
managers on their experience of organising and delivering DVA support during the pandemic 376 
will help contextualise the ITS and clinician interview data while also comparing and 377 
contrasting primary care clinician referrals with patient self-referrals to DVA agencies. The 378 
quantitative and qualitative workstreams will be given equal significance.  379 
We will contextualise the findings in the light of learning from parallel rapid research that has 380 
been undertaken during the pandemic and emergent policy and practice outputs relevant to 381 
the study. In particular, we will synthetise our findings with an aligned study on the 382 
experiences of non-IRIS general practitioners providing DVA support during the pandemic 383 
(53). Our PPI&E groups’ insights regarding experiences of DVA survivors seeking support 384 
from primary health care and domestic violence services remotely will be informing the 385 
synthesis and their commentary on our findings will be integrated into the analysis. 386 
DISCUSSION 387 
Relevance  388 
The PRECODE study will combine quantitative and qualitative methods to explore and 389 
explain the dynamics of DVA referrals before and during the COVID-19 epidemic in the UK.  390 
We will be focusing on new evidence gaps created by the uncertainty about how general 391 
practices responded to (live) online DVA training and how they adapted their consultation 392 
methods in relation to DVA in the context of the COVID-19 pandemic. The importance of 393 





numbers likely to increase in the coming year(s), requiring an effective response from the 395 
NHS, particularly general practice.    396 
 397 
The imposing of severe lockdown measures during the COVID-19 pandemic led to closure 398 
of face-to-face DVA services and consequential reduction in DVA referrals in the UK (despite 399 
increased DVA prevalence). Evidence-based, continual and effective remote support of DVA 400 
survivors and referrals to DVA service providers is crucial, as it is likely that even when 401 
social distancing is relaxed, a smaller proportion of general practice consultations will be 402 
face-to-face (54). Analysing the change in referrals and the adaptation of clinical responses 403 
to DVA during the pandemic is crucial in underpinning future planning, and this is the first 404 
mixed-method study to do this on a national scale using qualitative interviews and over four 405 
years of referrals time series data.    406 
 407 
Strengths and limitations 408 
Key strengths of our study design are the rapid mixed method synthesis of diverse evidence 409 
sources. Both the quantitative and qualitative methodologies of the study are well-410 
established and widely used technical frameworks. The mixed method approach will allow 411 
for a broader and more granular exploration of the primary care response to DVA during the 412 
pandemic than quantitative or qualitative methods alone. The triangulation of quantitative 413 
and qualitative findings using rapid analysis and synthesis methods successfully applied 414 
previously in the context of COVID-19 research (55, 56), will allow for a rapid assessment of 415 
the variation, relevance, feasibility, and safety of primary care responses to DVA before and 416 
during the pandemic and its aftermath.  417 
Further strength lies in the multi-professional/multi-agency collaborative approach linking 418 
general practice to the DVA sector. The study team members have led the field of domestic 419 
violence and health research in the UK for almost two decades, combining quantitative 420 





sectional and longitudinal interview and ethnographic studies) and systematic co-production 422 
of research with third sector partners. Team members have diverse expertise around the 423 
development, delivery and testing of DVA interventions. Our landmark IRIS trial is the basis 424 
of a nationally commissioned training and advocacy programme linking general practice to 425 
the DVA sector. Team members work to improve and promote the healthcare response to 426 
DVA in the UK and internationally, work in strong partnership with service users, the DVA 427 
sector, including close collaboration with IRISi, and the RCGP, and they seek opportunities 428 
to disseminate findings internationally and to influence UK policy. Team members also lead 429 
evidence-based innovation in the health care response to DVA and are committed to 430 
influencing system change within health services and the DVA sector.  431 
The study team will actively involve three service user expert groups. Throughout they will 432 
provide valuable insights into the perspectives and experiences of survivors. Finally, the 433 
study will benefit from including the views of different professional groups with expertise and 434 
experience in DVA and without a specific role in this area.  435 
There are three possible limitations to this study. The first limitation concerns the possible 436 
generalisability and transferability of the findings to non-IRIS practices. Although we will 437 
ensure the diversity of recruited practices in terms of size, location and population, as well as 438 
the diversity of research participants, as the study is focusing on the pandemic responses of 439 
IRIS-trained general practices to affected patients, the findings will not necessarily be 440 
applicable or relevant to non-IRIS trained practices (consisting the majority of general 441 
practices in the UK). We will mitigate this by integrating our work with parallel research 442 
exploring the experiences of general practitioners with remote consultations in non-IRIS 443 
practices in the UK (53). This triangulation work will support the development of resources 444 
and guidance to all clinicians working in primary care, with or without IRIS specific training. 445 
These resources will be developed with input from primary health care stakeholders from 446 





The second limitation is potential participation bias: the views of general practice 448 
professionals participating in the interview study might reflect the narratives of those 449 
individuals who may have been more experienced in or more engaged with the management 450 
of DVA identification and referral or more favourably disposed to the IRIS programme. 451 
Equally, advocate educators participating in the interview study might reflect the views of a 452 
self-selected group of professionals experienced in delivering DVA training and support.  453 
Finally, the lack of patient research participant voice within the study will limit the 454 
interpretation of findings. As a result, although the perspectives of professionals will give 455 
indication of some of the barriers that might prevent patients from disclosing DVA in general 456 
practice, and the study will be guided by the perspectives of PPI&E members, our findings 457 
will not fully explain why some people affected by DVA do not seek or accept professional 458 
support during the pandemic. We will endeavour to interpret our findings in the light of 459 
relevant academic and policy outputs exploring survivor experiences of the pandemic.  460 
Implications for practice  461 
Enabling services to respond effectively to DVA is a UK policy priority (23, 57-59). Our study 462 
will support the implementation of this policy by generating and disseminating mixed-method 463 
evidence about the primary care response to DVA during the COVID-19 pandemic. Our 464 
findings will inform primary care and DVA service responses in the UK and other countries 465 
implementing remote clinical consultations, as they re-configure during the pandemic and 466 
beyond, including the interface between DVA and the delivery of primary care, training, and 467 
support for patients identified by front-line practitioners. We will formulate specific 468 
recommendations to improve online training and guidance on how primary care clinicians 469 
can safely and effectively address DVA in remote consultations. The recommendations will 470 
consider the needs of both IRIS and non-IRIS trained practices and ways in which DVA 471 
training and resources can be relevant and more widely available to general practices across 472 





Given the highly sensitive nature of DVA research, we will adopt trauma-informed 474 
dissemination and data sharing approaches, still consistent with open science (60, 61). 475 
Findings from our synthesis will directly inform policy on training and support for general 476 
practices by establishing bi-directional communication with policy makers, commissioners, 477 
health service providers, service users, and third sector organisations. As co-produced 478 
research with IRISi, the RCGP and PPI&E members, we will rapidly funnel evidence to 479 
support policy and practice nationally. Our evidence, resources and guidance will be open 480 
access and available to policymakers, commissioners, services, and front-line practitioners. 481 
We also expect to inform future national calls for evidence that feed into policy about DVA, 482 
local needs assessments and commissioning of both health and frontline DVA programmes 483 
and services.  484 
As with other health inequalities and adversities during the pandemic, although DVA has 485 
been made more visible in the last year, the health and domestic abuse sectors are 486 
struggling globally to re-configure services and develop new strategies. The study will drive 487 
inter-sectoral UK policy with relevance globally, by contributing resources and guidance for 488 
primary care clinicians addressing DVA using remote consultations. These will be vital in 489 
supporting safe and effective care for affected patients as primary care re-formats post-490 
pandemic. 491 
 492 
LIST OF ABBREVIATIONS  493 
AIC - Akaike Information Criterion  494 
BIC - Bayesian Information Criterion  495 
CCG - Clinical Commissioning Group 496 





GP – general practitioner  498 
HCRW - Health and Care Research Wales 499 
HRA - Health Research Authority 500 
IDREC - Inter-Divisional Research Ethics Committee 501 
IRR - incidence rate ratios  502 
IRIS - Identification and Referral to Improve Safety 503 
ITS - interrupted-time series  504 
JSNA - Joint Strategic Needs Assessment  505 
MRC - Medical Research Council 506 
NHSE - National Health Service England  507 
NICE - National Institute for Health and Care Excellence 508 
ONS -Office for National Statistics  509 
PPI&E - patient and public involvement and engagement 510 
PRECODE - Primary Care Response to Domestic Violence and Abuse in the Covid-19 511 
Pandemic: interrupted time series and qualitative study 512 
RAP - Rapid Assessment Process 513 
RCGP - Royal College of General Practitioners 514 
UK - United Kingdom 515 
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